These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 14688308)

  • 1. Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis.
    Bonder CS; Ajuebor MN; Zbytnuik LD; Kubes P; Swain MG
    J Immunol; 2004 Jan; 172(1):45-53. PubMed ID: 14688308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes.
    Jaruga B; Hong F; Sun R; Radaeva S; Gao B
    J Immunol; 2003 Sep; 171(6):3233-44. PubMed ID: 12960353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1--relevance for concanavalin A-induced hepatitis.
    Wolf D; Hallmann R; Sass G; Sixt M; Küsters S; Fregien B; Trautwein C; Tiegs G
    J Immunol; 2001 Jan; 166(2):1300-7. PubMed ID: 11145713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners.
    Sun R; Tian Z; Kulkarni S; Gao B
    J Immunol; 2004 May; 172(9):5648-55. PubMed ID: 15100309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midzonal necrosis of the liver after concanavalin A-injection.
    Satoh M; Kobayashi K; Ishii M; Igarashi T; Toyota T
    Tohoku J Exp Med; 1996 Oct; 180(2):139-52. PubMed ID: 9111763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-C chemokine ligand 2/monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4 production and is hepatoprotective in T cell-mediated hepatitis in the mouse.
    Ajuebor MN; Hogaboam CM; Le T; Swain MG
    J Immunol; 2003 May; 170(10):5252-9. PubMed ID: 12734374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic advantage of anti-VAP-1 over anti-α4 integrin antibody in concanavalin a-induced hepatitis.
    Lee WY; Salmi M; Kelly MM; Jalkanen S; Kubes P
    Hepatology; 2013 Oct; 58(4):1413-23. PubMed ID: 23686782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death.
    Chen D; McKallip RJ; Zeytun A; Do Y; Lombard C; Robertson JL; Mak TW; Nagarkatti PS; Nagarkatti M
    J Immunol; 2001 May; 166(10):5889-97. PubMed ID: 11342603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A-II suppressed concanavalin A-induced hepatitis via the inhibition of CD4 T cell function.
    Yamashita J; Iwamura C; Sasaki T; Mitsumori K; Ohshima K; Hada K; Hara N; Takahashi M; Kaneshiro Y; Tanaka H; Kaneko K; Nakayama T
    J Immunol; 2011 Mar; 186(6):3410-20. PubMed ID: 21300819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronin 1 is dispensable for leukocyte recruitment and liver injury in concanavalin A-induced hepatitis.
    Siegmund K; Lee WY; Tchang VS; Stiess M; Terracciano L; Kubes P; Pieters J
    Immunol Lett; 2013 Jun; 153(1-2):62-70. PubMed ID: 23856257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL3/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver.
    Ajuebor MN; Hogaboam CM; Le T; Proudfoot AE; Swain MG
    Eur J Immunol; 2004 Oct; 34(10):2907-18. PubMed ID: 15368307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glt25d2 Knockout Directly Increases CD25+CD69- but Decreases CD25-CD69+ Subset Proliferation and is Involved in Concanavalin-Induced Hepatitis.
    Hao X; Liu R; Zhang Y; Li Y; He Q; Huang Y; Jiang Y; Ma J; Li P; Wei H
    Cell Physiol Biochem; 2018; 50(3):1186-1200. PubMed ID: 30355948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorogenic acid ameliorated concanavalin A-induced hepatitis by suppression of Toll-like receptor 4 signaling in mice.
    Yuan Y; Gong X; Zhang L; Jiang R; Yang J; Wang B; Wan J
    Int Immunopharmacol; 2017 Mar; 44():97-104. PubMed ID: 28088700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6.
    Mizuhara H; O'Neill E; Seki N; Ogawa T; Kusunoki C; Otsuka K; Satoh S; Niwa M; Senoh H; Fujiwara H
    J Exp Med; 1994 May; 179(5):1529-37. PubMed ID: 8163936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-selectin mediates leukocyte rolling in concanavalin-A-induced hepatitis.
    March S; Garcia-Pagán JC; Massaguer A; Pizcueta P; Panés J; Engel P; Bosch J
    Liver Int; 2005 Oct; 25(5):1053-60. PubMed ID: 16162166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of sinusoidal endothelial cells of the liver in concanavalin A-induced hepatic injury in mice.
    Knolle PA; Gerken G; Loser E; Dienes HP; Gantner F; Tiegs G; Meyer zum Buschenfelde KH; Lohse AW
    Hepatology; 1996 Oct; 24(4):824-9. PubMed ID: 8855184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver.
    Zwacka RM; Zhang Y; Halldorson J; Schlossberg H; Dudus L; Engelhardt JF
    J Clin Invest; 1997 Jul; 100(2):279-89. PubMed ID: 9218504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.
    Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
    Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel accessory role of neutrophils in concanavalin A-induced hepatitis.
    Hatada S; Ohta T; Shiratsuchi Y; Hatano M; Kobayashi Y
    Cell Immunol; 2005 Jan; 233(1):23-9. PubMed ID: 15893298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Antidepressant Mirtazapine Inhibits Hepatic Innate Immune Networks to Attenuate Immune-Mediated Liver Injury in Mice.
    Almishri W; Shaheen AA; Sharkey KA; Swain MG
    Front Immunol; 2019; 10():803. PubMed ID: 31031775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.